Profil
Patrick Yue is Chief Medical Officer at Sirius Therapeutics since 2024.
Formerly, Dr. Yue was Senior Vice President-Clinical Development at Centessa Pharmaceuticals Plc from 2023 to 2024, Executive Director-Clinical Science at Global Blood Therapeutics, Inc. from 2020 to 2023, and Executive Director-Clinical Development at Portola Pharmaceuticals LLC from 2016 to 2020.
Education includes an undergraduate degree from California Institute of Technology in 1995 and a doctorate from Washington University School of Medicine in 1999.
Postes actifs de Patrick Yue
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Patrick Yue
| Sociétés | Poste | Fin |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/06/2024 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2023 |
| PORTOLA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2020 |
Formation de Patrick Yue
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Washington University School of Medicine
Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centessa Pharmaceuticals Plc
Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
















